Better Sleep Blend (BSB) 

#

Better Sleep Blend
Supplement’s Present

Dosage (mg/dose)

1

Valerian Extract (root)

150mg

2

Chamomile Extract (flower) 

100mg

3

GABA (Gamma-Aminobutyric Acid)

100mg 

4

L-Tryptophan

100mg

5

Lemon Balm Extract (Melissa officinalis) (stem, leaves, flower) 

100mg 

6

Passion Flower Extract (stem, leaves, flower)

100mg

7

Melatonin 

2mg


Table of Contents — Better Sleep Blend (BSB)

Supplements Present in BSB: Origin & Historical Context 

Botanical Overview 

Geographic Origin

Cultural Origins

Traditional Use Patterns 


Krafted Formulation Rationale — Supplements Krafted Different 

Sourcing Standard

Standardization Targets


Purity Thresholds + Third-Party Testing Plan

Formulation Logic (phenotype ratios + excipient rationale)

Delivery Form Justification (capsule vs powder/liquid)

Clinical Mindset + Future FDA Pathway Readiness

Pre-Clinical Biological Rationale

Metabolism & Mechanistic Pathways

Safety, Interactions & Quality Considerations

Bioavailability & Dose Considerations (non-prescriptive)

Known Safety Profile & Common Side Effects

Contraindications / Medication Interactions 

Quality Risks 

Quality Control Solutions 

BSB Clinical Investigation Landscape

Preclinical & Mechanistic Research Directions

Emerging Applications & Knowledge Gaps

Evidence Tier Summary 


Regulatory Status & Transparency

Dietary Supplement Positioning + Structure/Function Language

Labeling Guardrails (no disease claims)

Manufacturing Standards (cGMP, COAs, lot traceability)

Documentation Discipline (internal QC/QA)

Patient Populations and Associated Benefits 

Primary Populations Studied

Secondary / Exploratory Populations

Contextual Use Considerations
(non-therapeutic, structure/function framing)


References

Core Reviews and High-Value Overviews

Clinical Trials  

Safety Signals, Interactions, and Adverse Events

Mechanism and Bioactive Constituents 

Phenotype/Processing, Identity, Metabolomics, and Quality Control 

Supporting Context 




Supplements Present in BSB: Origin & Historical Context 

The ingredients in this blend are characterized by extensive histories of traditional medicinal use across diverse cultures, primarily as remedies for sleep disorders, anxiety, and general psychological well-being.

Valerian (Valeriana officinalis)

• Botanical Overview: It is a flowering plant whose underground organs (roots) are utilized for medicinal preparations.

• Geographic Origin: Valerian is indigenous to Europe and parts of Asia.

• Cultural Origins & Traditional Use: It has been used for centuries by herbalists and physicians to treat nervousness and trembling. In many cultures, it is traditionally applied as a mild sedative and tranquilizer to aid the induction of sleep. In modern times, it is a frequent ingredient in herbal medicines and is a popular self-prescribed treatment for insomnia in the United States.

Chamomile (Matricaria chamomilla and Chamaemelum nobile)

• Botanical Overview: Belonging to the Asteraceae family, the two primary species used for health are German chamomile (M. chamomilla) and Roman chamomile (C. nobile). They are aromatic annual or perennial herbs with daisy-like white flowers.

• Geographic Origin: Chamomile is indigenous to Europe and Asia, but is also grown in North Africa and North America. Hungary is a major producer of the plant's biomass.

• Cultural Origins & Traditional Use: The name is derived from the Greek words Chemos and Melos, meaning "ground apple". It was introduced to India by the Mughals and is considered a "cure all" in Europe. Traditionally consumed as a tea or tonic, it is used to treat anxiety, inflammation, spasms, and as a sedative. Other applications include treating flatulence, colic, hysteria, depression, and aiding wound healing.

GABA (Gamma-Aminobutyric Acid)

• Botanical Overview: GABA is a non-protein amino acid found naturally in grains, legumes, and plants. It is particularly abundant in fermented foods, such as kimchi and probiotic-fermented dairy.

• Origin: It is the primary inhibitory neurotransmitter in the central nervous system of mammals, essential for maintaining neural homeostasis.

• Traditional Use Patterns: While historically recognized for its neurotransmitter role, GABA is increasingly used in functional foods for non-pharmaceutical sleep improvement. It is applied to shorten sleep latency and extend non-rapid eye movement (NREM) sleep.

L-Tryptophan

• Botanical Overview: This is an essential amino acid, meaning it cannot be synthesized by the human body and must be obtained through dietary ingestion.

• Origin: It serves as the biochemical precursor for both serotonin and melatonin.

• Traditional Use Patterns: Investigations into its hypnotic effects began in the 1970s and 80s, leading to its use as a therapeutic agent for chronic insomnia. It is also used to consolidate sleep-wake rhythms in newborns. In traditional animal models, it has demonstrated immuno-enhancing effects and the ability to improve nocturnal rest.

Melissa officinalis (Lemon Balm)

• Botanical Overview: A perennial herb in the mint family (Lamiaceae), known for its lemony aroma and taste.

• Geographic Origin: Native to the Mediterranean region and West Asia, it is now naturalized worldwide, including North Africa and North America.

• Historical Context: Its medicinal use spans over 2,000 years, with records appearing in the Historica Plantarum around 300 B.C.. It was described by Hippocrates and Dioscorides, and later recommended by Avicenna in the Middle Ages to "strengthen the heart".

• Traditional Use Patterns: Early use focused on gastrointestinal disorders. Over time, it became a staple in Saracen medicine for insomnia, anxiety, and depression. It has also been traditionally used to restore youth, prevent baldness, and manage epilepsy or amnesia.

Passion Flower Extract (Passiflora incarnata)

• Botanical Overview: A perennial climbing vine featuring white and purple flowers and edible fruit.

• Geographic Origin: It is native to South America, Australia, Southeast Asia, and the Southeastern United States.

• Cultural Origins & Traditional Use: Its medicinal application originated with Native Americans. Historically, it is most prized as a remedy for insomnia and anxiety. It is also used for neuralgia, convulsions, spasmodic asthma, and as an adjuvant in treating opiate withdrawal or morphine dependence.

Melatonin

• Botanical Overview/Source: Melatonin is an endogenous hormone synthesized in the pineal gland, though it also occurs naturally in edible plants like corn, rice, ginger, and tomatoes.

• Origin: It is produced through a light-dependent process from tryptophan and serotonin.

• Traditional Use Patterns: It is recognized as a first-line pharmacological therapy for insomnia. Beyond sleep, it is traditionally used for jet lag management, migraine prophylaxis, and to regulate circadian rhythm disorders. In the aging body, its supplementation is used to counteract the "melatonin deficiency state" associated with disrupted sleep cycle

Pre-Clinical Biological Ration for BSB

The biological rationale for combining these supplements lies in their multi-targeted approach to the central nervous system, utilizing synergistic pathways to enhance GABAergic inhibition, regulate circadian rhythms, and dampen the body’s stress response.

1. GABAergic Modulation and Enzymatic Inhibition

The primary mechanistic pillar of this blend is the enhancement of Gamma-Aminobutyric Acid (GABA), the brain's main inhibitory neurotransmitter.

• Direct Support: Supplemental GABA acts through the gut-brain axis, potentially triggering the vagus nerve to communicate relaxation signals directly to sleep-regulating centers in the brain.

• Enzymatic Preservation: Valerian and Lemon Balm (Melissa officinalis) contain active compounds like valerenic acid and rosmarinic acid, which inhibit GABA transaminase, the enzyme responsible for breaking down GABA. By preventing this breakdown, these herbs allow higher levels of GABA to accumulate in the brain.

• Receptor Binding: Chamomile and Passion Flower contain the flavonoid apigenin, which binds to benzodiazepine receptors in the brain, exerting a mild sedative and anxiolytic effect similar to pharmacological sleep aids but with a better safety profile.

2. The Indole Pathway and Circadian Regulation

The blend leverages the biochemical conversion of amino acids to regulate the sleep-wake cycle.

• The Metabolic Chain: L-Tryptophan serves as the fundamental building block for this pathway; it is first metabolized into serotonin and subsequently converted into melatonin through a light-dependent process.

• Direct Hormone Signaling: Supplemental Melatonin bypasses this synthesis chain to directly activate MT1 and MT2 receptors in the suprachiasmatic nucleus, which inhibits wake-promoting signals and "opens the sleep gate".

• Metabolic Synergy: Interestingly, GABA can be converted into gamma-hydroxybutyrate (GHB), a metabolite that may increase the expression of melatonin receptors, further sensitizing the brain to sleep signals.

3. Neuroendocrine and HPA Axis Regulation

A major obstacle to sleep is the overactivation of the Hypothalamic-Pituitary-Adrenal (HPA) axis, often caused by chronic stress.

• Cortisol Suppression: Ingredients like Lemon Balm and GABA have been shown to reduce serum cortisol levels and pro-inflammatory cytokines that otherwise trigger neural excitation.

• Cholinergic Modulation: Lemon Balm also inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, which may help stabilize mood and cognitive functions often disrupted by poor sleep.

4. Synergistic Interactions

The combination of these ingredients is more effective than the sum of its parts due to synergistic pharmacodynamics.

• Valerian and Lemon Balm: This specific pair has been clinically shown to improve sleep quality in both children and adults by combining enzymatic inhibition with broad-spectrum CNS sedation.

• Chamomile and GABA: These two work together to restore the GABA/glutamate balance, ensuring that excitatory signals (glutamate) are buffered by inhibitory ones (GABA), which is essential for maintaining deep non-rapid eye movement (NREM) sleep.

Analogy for Understanding: Think of your brain as a busy construction site at the end of the day. Tryptophan and Melatonin act as the site foreman, blowing the whistle to signal that the shift is over. Valerian and Lemon Balm act as security guards who prevent the "cleanup crew" (enzymes) from accidentally throwing away the "silence" (GABA) that was just created. Finally, Chamomile and Passion Flower act as noise-canceling headphones, muffling the remaining background chatter so the site can finally go quiet.

BSB Clinical Research Landscape

The human clinical investigation landscape for these supplements ranges from well-established pharmacological roles for hormone precursors to promising, yet often heterogeneous, results for botanical extracts. While traditional use spans over 20 centuries, modern research is increasingly focused on standardizing extracts and validating specific neurochemical pathways.

Preclinical & Mechanistic Research Directions

Current preclinical research is heavily focused on the modulation of the GABAergic system as a unifying mechanism for these ingredients.

• Enzymatic Inhibition and Receptor Binding: Preclinical models for Lemon Balm (Melissa officinalis) and Valerian have demonstrated that their active components, such as rosmarinic acid and valerenic acid, inhibit GABA transaminase, the enzyme responsible for GABA degradation. Passionflower has been shown in hippocampal slice preparations to elicit direct GABAA currents, though this effect appears highly dependent on the amino acid content of the specific extract used.

• Neurotransmitter Synthesis and Turnover: L-Tryptophan research emphasizes its role as a mandatory precursor, where its oral administration significantly elevates brain serotonin and subsequently nocturnal melatonin levels. Emerging animal models suggest Lemon Balm may also offer antidepressant activity by regulating 5-HT (serotonin) turnover in specific brain regions.

• Alternative Pathways: Beyond GABA, researchers are investigating cholinergic modulation. Both Lemon Balm and Brahmi act as acetylcholinesterase inhibitors, which provides a mechanistic basis for their emerging use in managing cognitive decline and agitation in Alzheimer’s patients.

Emerging Applications & Knowledge Gaps

Human trials are expanding beyond simple insomnia to investigate these ingredients in specialized medical contexts.

• Emerging Clinical Applications:

    ◦ Perioperative and Procedural Anxiety: Multiple randomized controlled trials (RCTs) have found that Passionflower and Lemon Balm can effectively reduce preoperative anxiety in patients undergoing spinal anesthesia or outpatient surgery, often with a lower incidence of "hangover" effects compared to benzodiazepines like midazolam or oxazepam.

    ◦ Gynecology and Cardiology: Lemon Balm has shown significant efficacy in reducing the severity of PMS symptoms in adolescents and improving quality of life in patients with chronic stable angina.

    ◦ Pediatric Use: Combinations of Valerian and Lemon Balm have shown promise in improving sleep quality and reducing restlessness in primary school children.

• Knowledge Gaps:

    ◦ Bioavailability Debates: There is significant academic debate regarding the ability of orally ingested GABA to cross the human blood-brain barrier in sufficient quantities, leading researchers to explore indirect modulation via the gut-brain axis and vagus nerve.

    ◦ Heterogeneity of Evidence: A major gap is the lack of Phase III trials and the high level of statistical heterogeneity in existing meta-analyses. Many studies suffer from small sample sizes, lack of standardized dosages, and "publication bias," where small negative studies are less likely to be published than positive ones.

Evidence Tier Summary

Tier

Supplement(s)

Summary of Human Evidence

Tier 1:High

Melatonin / Tryptophan

Recognized as first-line pharmacological therapy for insomnia; clear metabolic pathway and consistent results in circadian regulation.

Tier 2: Moderate

Lemon Balm / Passionflower

Validated by EMA and other pharmacopoeias for "traditional use"; strong results in reducing anxiety/stress, but efficacy in severe clinical disorders requires more large-scale data.

Tier 3: Promising

Chamomile / Valerian

Widely used with a benign safety profile; however, meta-analyses often show inconsistent results due to extract variability and methodologic flaws in trials.

Tier 4: Emerging

GABA

Growing interest in functional foods and probiotics; however, central mechanisms in humans (direct vs. indirect) are still being elucidated.

Analogy for Understanding: Evaluating the clinical landscape of these supplements is like looking at a mountain range through fog. For Melatonin and Tryptophan, the peak is clear because we understand exactly how they work. For Lemon Balm and Passionflower, we can see the shape of the mountain clearly, but we aren't exactly sure of the best path to the top (the optimal dose). For others like Valerian or GABA, the fog is thicker; we know the mountain is there because people have been climbing it for centuries, but modern science is still trying to map the exact terrain.


Krafted Formulation Rationale - Supplements Krafted Different 

This "Krafted" formulation rationale integrates 2,000 years of traditional medicinal history with high-tier pharmaceutical standards to address the complexities of modern sleep disorders.

1. Sourcing Standard

Quality begins with rigorous selection based on agroecological conditions and plant phenotypes.

• Soil and Yield: Research indicates that soil type significantly impacts phytochemical yield; for example, Lemon Balm (Melissa officinalis) thrives in heavier soils (cambisol and chernozem), which produce nearly double the leaf yield of lighter soils.

• Harvesting Condition: For aromatic herbs like Lemon Balm, fresh material often yields a higher content of essential oils compared to dry states.

• Genetic Chemotypes: Sourcing must account for specific chemotypes; Lemon Balm is categorized into geranial/thymol or geranial/neral profiles, while Valerian and Chamomile compositions vary widely based on population genetics.

• Species Identification: Using the highest-yielding species is vital; for instance, German Chamomile (M. chamomilla) is identified as having more biological effects than other species, and Passiflora incarnata is selected for having the highest GABA content among 21 examined plants.

2. Standardization Targets

To ensure consistent biological activity, specific biomarker thresholds are maintained according to international pharmacopoeias:

• Chamomile: Must contain at least 0.25% to 0.3% apigenin-7-glucoside.

• Passionflower: Standardized to a minimum of 2.0% total flavonoids, expressed as vitexin.

• Lemon Balm: Primarily standardized to Rosmarinic Acid (RA), often targeted at >2% to 6% concentration.

• Valerian: Typically targeted at 0.8% valerenic acids to ensure reliable sedative activity.

3. Purity Thresholds + Third-Party Testing Plan

Because the FDA does not regulate supplements as rigorously as drugs, unregulated excipients and dosage inaccuracies are major risks.

• USP Verification: Melatonin supplements have shown a content variance of -83% to +478% of the labeled amount; thus, "Krafted" products prioritize USP-verified sourcing to guarantee quality and dosing accuracy.

• Analytical Characterization: Toxicity is assessed by analyzing leaves and soil for heavy metals such as cadmium, copper, and lead using Graphite Furnace Atomic Absorption Spectrometry (GFAAS).

• Safety Monitoring: The testing plan includes screening for allergic reactions to unregulated excipients and clinical monitoring of liver function and glucose levels.

Formulation Logic

The logic focuses on synergistic pharmacodynamics rather than high-dose single ingredients.

• The Synergy Axis: Combinations of Valerian and Lemon Balm are clinically validated to improve sleep quality in both children and menopausal women more effectively than isolated use.

• Neurotransmitter Balancing: GABA is paired with agents like L-Theanine to synergistically shorten sleep latency.

• Excipient Rationale: Use of microcrystalline cellulose is standard for stable encapsulation, while innovative food-grade carriers like whey protein or chitosan are considered to shield GABA from enzymatic degradation in the gut.

Delivery Form Justification

The choice of delivery form is driven by metabolic stability and the blood-brain barrier (BBB).

• Capsules vs. Liquids: While liquid extracts (tinctures) provide rapid absorption, encapsulation is preferred for ingredients like GABA to shield them from the harsh gastrointestinal environment, effectively increasing their potential for transport into the central nervous system.

• Lipid-Based Carriers: To solve the problem of poor tissue permeability in botanical extracts, "Krafted" logic utilizes nanoemulsions or liposomes to enhance clinical acceptability and bioavailability.

Clinical Mindset + Future FDA Pathway Readiness

The formulation is designed with a Decision-Making Diagnosis mindset, moving beyond simple symptom relief toward standardized therapeutic outcomes.

• GRAS Status: Ingredients like Chamomile and Melatonin already hold Generally Regarded as Safe (GRAS) status for use in OTC dietary supplements and food products.

• Diagnostic Alignment: Research is framed using DSM-5 and ICSD-3 criteria, ensuring that clinical results are ready for integration into mainstream medical classifications.

• Standardized Validation: While many botanicals are recognized for "traditional use," a "Krafted" mindset aims for "well-established medicinal use" via larger Phase III trials that can eventually support formal FDA-approved claims, similar to melatonin receptor agonists like ramelteon.

Analogy for Understanding: A "Krafted" formulation is like building a performance car. Standard supplements often just provide a "big engine" (high dose). Sourcing the right chemotypes is like choosing a high-grade fuel; standardization is the precision tuning that ensures every part works exactly as intended; and nano-encapsulation is the aerodynamic frame that ensures the fuel actually reaches the engine (the brain) instead of being burned off on the road (the gut).


Safety, Interactions & Quality Considerations

This comprehensive safety and quality overview of the supplement blend—comprising Valerian, Chamomile, GABA, L-Tryptophan, Lemon Balm (Melissa officinalis), Passion Flower, and Melatonin—is drawn from pharmacological reviews and clinical investigation data within the sources.

Bioavailability & Dose Considerations

The efficacy of these ingredients is heavily influenced by their metabolic pathways and delivery formats.

• Melatonin: Oral bioavailability varies significantly (1% to 74%), largely depending on the formulation and dosage. Studied doses range from 0.1 mg to 10 mg, typically administered up to two hours before bedtime.

• GABA: While its ability to cross the human blood-brain barrier is debated, clinical studies using typical dietary doses of 100–300 mg/day have consistently reported improved sleep outcomes, potentially mediated by the gut-brain axis or transporter-mediated active transport.

• Botanical Extracts: Clinical trials for Lemon Balm have utilized a wide range of doses, from 80 mg to 5000 mg/day, often standardized to >2% to 6% rosmarinic acid. Passion Flower is typically standardized to a minimum of 2.0% total flavonoids. Valerian doses in trials range from 225 mg to 1215 mg/day, usually targeted at 0.8% valerenic acids.

• L-Tryptophan: Brain transport of this essential amino acid can be limited by competition with other large neutral amino acids that bind to the same transporters.

Known Safety Profile & Common Side Effects

The ingredients generally demonstrate a favorable safety profile, with few serious adverse events reported in healthy adults.

• Common Effects: Mild side effects include drowsiness, daytime sedation, nausea, and headaches, particularly with higher doses of Melatonin or Lemon Balm.

• Cognitive Impact: Unlike synthetic sedatives, botanical ingredients like Valerian and Passion Flower are noted for their lack of morning "hangover" effects or impaired job performance.

• Specific Risks: High doses of Melatonin may impair glucose tolerance. One case report for Lemon Balm indicated a risk of withdrawal syndrome (anxiety and irritability) after the cessation of very high chronic intake (four cups of infusion daily for two months).

• General Status: Most of these ingredients, including Chamomile and Melatonin, hold Generally Regarded as Safe (GRAS) status for use in dietary supplements and food products.

Contraindications & Medication Interactions

Synergistic effects with pharmacological agents require clinical caution.

• Sedative Synergies: Concomitant use with synthetic sedatives (e.g., benzodiazepines like lorazepam) is not recommended, as it may result in excessive sedation, hand tremors, or dizziness.

• Metabolic Inhibitors: Melatonin metabolism is primarily mediated by the CYP1A2 enzyme; caution is advised when using it with potent CYP1A2 inhibitors like fluvoxamine.

• Medical Conditions: Lemon Balm is contraindicated for individuals with thyroid disorders. Melatonin should be used with caution in patients with autoimmune diseases or those who have undergone an organ transplant.

• Bleeding Risk: Herbs such as Chamomile and Lavender (often found in sleep blends) have anticoagulant properties and may increase bleeding risks when used with blood thinners like warfarin or heparin.

Quality Risks

The primary risk in the supplement landscape is the lack of standardized regulation, leading to significant product variability.

• Dosage Inaccuracy: A study of Melatonin supplements found that actual content varied from -83% to +478% of the labeled amount.

• Phytochemical Variation: The composition of Valerian and Lemon Balm is highly variable due to soil type, harvesting time, and population genetics.

• Contaminants: Historically, L-Tryptophan was associated with Eosinophilia-Myalgia Syndrome (EMS) due to a single batch of contaminated material, highlighting the need for rigorous purity testing.

Quality Control Solutions

To mitigate these risks, the sources recommend specific standardization and verification steps.

• Third-Party Verification: Choosing supplements labeled as "USP verified" (United States Pharmacopeia) can guarantee quality and dosing accuracy.

• Standardization Targets:

    ◦ Valerian: 0.8% valerenic acids.

    ◦ Passion Flower: 2.0% total flavonoids expressed as vitexin.

    ◦ Chamomile: 0.25–0.3% apigenin-7-glucoside.

• Toxicity Screening: Analytical characterization using Graphite Furnace Atomic Absorption Spectrometry (GFAAS) should be used to analyze leaves and soil for heavy metals like cadmium and lead.

Analogy for Understanding: Using a non-standardized supplement blend is like ordering a meal where the chef doesn't use a measuring cup. For one "dish" (Melatonin), you might get five times the intended amount of salt; for another (Valerian), the ingredients might have been swapped for a weaker variety because the soil was poor. USP verification and standardization act as the master recipe and kitchen scales, ensuring that every "meal" provides exactly the nutrition intended without accidental "poisoning" (medication interactions).

Regulatory Status & Transparency

To align this Krafted sleep blend with FDA standards for dietary supplements, the following regulatory and manufacturing framework is established based on the provided sources.

Regulatory Status & Transparency

The ingredients in this blend are categorized as dietary supplements rather than drugs.

• GRAS Status: Major components like German Chamomile and Melatonin are classified as Generally Regarded as Safe (GRAS) for use in food and over-the-counter dietary products.

• Transparency Requirements: Sources highlight a significant risk of content variance in unregulated products; for example, one study found Melatonin supplements varied from -83% to +478% of the labeled amount. Transparency is maintained by utilizing USP-verified sourcing to guarantee that the dosage on the label matches the physical content.

• International Recognition: Passionflower and Lemon Balm are recognized in multiple international pharmacopoeias, supporting their status as established botanical ingredients.

Manufacturing Standards (cGMP, COAs, Lot Traceability)

Compliance with Current Good Manufacturing Practices (cGMP) ensures the identity, purity, and strength of the blend.

• Certificates of Analysis (COAs): Every batch requires a COA to verify standardization targets. This includes ensuring Passionflower contains a minimum of 2.0% flavonoids (expressed as vitexin) and Chamomile contains at least 0.25% apigenin-7-glucoside.

• Lot Traceability: Manufacturers must track ingredients from soil to shelf. Sourcing is influenced by soil type (e.g., Lemon Balm yields are nearly double in heavier cambisol vs. lighter soils), necessitating strict documentation of origin.

• Purity Thresholds: Testing includes Graphite Furnace Atomic Absorption Spectrometry (GFAAS) to ensure heavy metals like cadmium, copper, and lead remain below safety thresholds.

Documentation Discipline (Internal QC/QA)

A rigorous internal Quality Control (QC) and Quality Assurance (QA) program is essential for validating the "Krafted" mindset.

• Phytochemical Fingerprinting: Documentation includes HPLC-DAD and LC-MS fingerprints to ensure that each lot of botanical extract contains the same ratio of active secondary metabolites, preventing batch-to-batch variation.

• Excipient Rationale: Internal documentation must justify the use of food-grade carriers (e.g., microcrystalline cellulose) and ensure they do not cause allergic reactions, as unregulated excipients in supplements can pose safety risks.

• Verification: Third-party testing plans are integrated into the QA process to provide an objective audit of the internal manufacturing results.




References

Core Reviews and High-Value Overviews

(Authoritative syntheses, umbrella reviews, and state-of-the-field analyses)

  • Bent S, Padula A, Moore D, Patterson M, Mehling W. Valerian for sleep: a systematic review and meta-analysis.Am J Med. 2006;119(12):1005–1012. doi:10.1016/j.amjmed.2006.02.026. PMID: 17145239; PMCID: PMC4394901.

  • Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol. 1999;51:505–512. doi:10.1211/0022357991772772.

  • Sah A, Naseef PP, Kuruniyan MS, et al. A comprehensive study of therapeutic applications of chamomile.Pharmaceuticals (Basel). 2022;15(10):1284. doi:10.3390/ph15101284. PMID: 36297396; PMCID: PMC9611340.

  • Mathews IM, Eastwood J, Lamport DJ, et al. Clinical efficacy and tolerability of lemon balm (Melissa officinalisL.) in psychological well-being: A review. Nutrients. 2024;16(20):3545. doi:10.3390/nu16203545. PMID: 39458539; PMCID: PMC11510126.

  • Janda K, Wojtkowska K, Jakubczyk K, et al. Passiflora incarnata in neuropsychiatric disorders – A systematic review. Nutrients. 2020;12(12):3894. doi:10.3390/nu12123894. PMID: 33352740; PMCID: PMC7766837.


Clinical Trials

(Human intervention studies assessing sleep, anxiety, or psychological outcomes)

  • Schulz H, Stolz C, Müller J. Effect of valerian extract on sleep polygraphy in poor sleepers: A pilot study.Pharmacopsychiatry. 1994;27:147–151. doi:10.1055/s-2007-1014295.

  • Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363–367. doi:10.1046/j.1365-2710.2001.00367.x. PMID: 11679026.

  • Harit MK, Mundhe N, Tamoli S Sr, et al. Randomized, double-blind, placebo-controlled study of Passiflora incarnata in stress and sleep problems. Cureus. 2024;16(3):e56530. doi:10.7759/cureus.56530. PMID: 38646244; PMCID: PMC11026993.

  • Paredes SD, Terrón MP, Cubero J, et al. Tryptophan increases nocturnal rest and alters melatonin and serotonin levels. Physiol Behav. 2007;90:576–582. doi:10.1016/j.physbeh.2006.11.007.

Safety Signals, Interactions, and Adverse Events

(Clinical pharmacology, tolerability, and interaction-relevant context)

  • Savage RA, Zafar N, Yohannan S, et al. Melatonin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Updated Feb 9, 2024.

  • Bent S, Padula A, Moore D, et al. Am J Med. 2006. (Also cited for tolerability and adverse-event reporting in valerian use.)

Mechanism and Bioactive Constituents

(Neurotransmission, circadian biology, receptor-level and pathway-level explanations)

  • Li S, Li Y, Xue C, et al. Progress in research on the mechanism of GABA in improving sleep. Foods.2025;14(22):3856. doi:10.3390/foods14223856. PMID: 41300013; PMCID: PMC12651798.

  • Jouvet M. Sleep and serotonin: An unfinished story. Neuropsychopharmacology. 1999;21:24S–27S. doi:10.1016/S0893-133X(99)00009-3.

  • Paredes SD, Barriga C, Reiter RJ, Rodríguez AB. Tryptophan as precursor of serotonin and melatonin: Sleep–wake and immune implications. Int J Tryptophan Res. 2009;2:23–36. doi:10.4137/IJTR.S1129.

Phenotype / Processing / Identity / Metabolomics / Quality Control

(Chemotypic variation, phytochemical identity, and standardization relevance)

  • Świąder K, Startek K, Wijaya CH. Therapeutic properties of lemon balm (Melissa officinalis L.): Novel findings and medical indications. J Appl Bot Food Qual. 2019;92:327–335.

  • Ghazizadeh J, Mohammadinasab R, Travica N, et al. Historical course of neuropsychiatric effects of lemon balm. Pharma Sci. 2021;28:14–19. doi:10.34172/PS.2021.35.

Supporting Context

(Epidemiology, disease burden, and clinical framing of sleep disorders)

  • Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. Sleep. 1999;22(Suppl 2):S347–S353.

  • Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia: An American Academy of Sleep Medicine review. Sleep. 2000;23:243–308.

  • Ohayon M. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev.2002;6:97–111. doi:10.1053/smrv.2002.0186.